Alcon AG | ALC - Ebit


Alcon AG reported $44M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
AstraZeneca USD 4.66B 1.5B Sep/2026
Bayer EUR 129M 626M Sep/2026
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 96.55M Sep/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 34M Sep/2026
Lonza CHF 673M 54M Jun/2025
Merck EUR 660M 437M Sep/2026
Novartis USD 5.14B 411M Sep/2026
Philips EUR 206M 435M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 3.6B Sep/2026
Smith & Nephew USD 505M 65M Jun/2026
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 1.29B 571M Dec/2025